Cold Plasma Market
完整報告名稱與涵蓋範圍
Cold Plasma Market by Application (Plasma Sterilization, Wastewater Treatment, Wound Healing, Surface Treatment, Coating, Packaging, Thin Film Deposition, Etching, Printing, Skin Treatment), by Regime (Low Pressure, Atmospheric) - Global Forecast to 2031
報告摘要
The global cold plasma market is projected to reach USD 3.03 billion by 2031 from USD 2.15 billion in 2026, at a CAGR of 7.1 % during the forecast period.
The growing need for effective, low-temperature sterilization and surface modification of medical devices is driving the adoption of cold plasma technology. Cold plasma enables non-thermal treatment of heat-sensitive medical devices while reducing reliance on harsh chemicals and minimizing material damage.
Increasing demand for sterile medical equipment, infection control, and advanced surface treatment, particularly for catheters, implants, surgical instruments, and other polymer-based devices, is expected to support market growth. Furthermore, rising healthcare expenditure, stringent sterilization requirements, and advancements in plasma-based medical technologies are likely to drive further adoption of cold plasma solutions.
“Based on industry, the medical industry segment of the cold plasma market is expected to register the highest share during the forecast period.”
The growing adoption of plasma-based solutions for wound healing, sterilization, disinfection, and surgical applications mainly drives the demand for cold plasma technology in the medical industry. The increasing prevalence of chronic wounds, rising demand for minimally invasive procedures, and growing emphasis on infection prevention are supporting the adoption of cold plasma systems across hospitals, clinics, and medical-device manufacturing facilities. Moreover, the focus on non-thermal sterilization, antimicrobial treatment, reduced chemical usage, patient safety, and environmentally friendly healthcare processes is encouraging the adoption of cold plasma technologies. Technological advancements in atmospheric-pressure plasma jets, plasma-based wound-care devices, and plasma sterilization systems are further expanding the scope of cold plasma applications, supporting the medical industry segment in registering the highest share during the forecast period.
“By application, the surface treatment & activation segment is expected to capture the highest CAGR of the cold plasma market.”
Based on application, the surface treatment & activation segment is anticipated to register the highest CAGR during the forecast period. This growth can be attributed to the increasing use of cold plasma to enhance surface adhesion, wettability, printability, and bonding properties across polymer & plastics, textiles, electronics, and automotive applications.
The non-thermal, environmentally friendly nature of cold plasma, along with its ability to reduce reliance on chemical treatments, is driving its adoption across industries. Moreover, advancements in plasma technology, development of application-specific systems, and increasing demand for efficient and customizable surface treatment solutions are expected to further accelerate segment growth.
“By regime, the low-pressure cold plasma segment is expected to register the highest CAGR in the cold plasma market.”
The low-pressure cold plasma segment is projected to record the highest CAGR, primarily due to its increasing use in high-precision manufacturing processes, particularly in semiconductor fabrication, electronics component processing, and specialized medical applications. The segment benefits from the ability to operate under controlled vacuum conditions, enabling precise plasma density, treatment uniformity, and repeatable process outcomes. Rising investments in advanced manufacturing facilities and the increasing integration of plasma-based processes into automated production lines are expected to further accelerate the adoption of low-pressure systems.
“Europe accounted for the largest share of the cold plasma market by region.”
The global cold plasma market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe is expected to account for a significant share of the global cold plasma market, supported by the increasing adoption of cold plasma technologies across medical, polymer & plastic, textile, and electronics industries, as well as the strong presence of key market players in the region.
The regional market is further supported by advanced manufacturing capabilities, stringent environmental regulations, growing demand for sustainable and chemical-free processing, and increasing investments in healthcare technologies. Moreover, the rising adoption of cold plasma for medical device sterilization, wound care, infection control, and industrial surface treatment, along with ongoing technological advancements and R&D activities, is expected to further drive market growth in Europe.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (45%), Tier 2 (25%), and Tier 3 (30%)
• By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
• By Region: North America (35%), Europe (25%), Asia Pacific (20%), Latin America (15%), and the Middle East & Africa (5%)
The major players operating in the cold plasma market are Apyx Medical (US), Nordson Corporation (US), Adtec Plasma Technology Co. Ltd. (Japan), P2i Ltd. (UK), Relyon Plasma GmbH (Germany), Henniker Plasma (UK), Enercon Industries Corporation (US), AcXys Plasma Technologies (France), Plasmatreat GmbH (Germany), Tantec A/S (Denmark), Europlasma NV (Belgium), Thierry Corp. (Germany), Surfx Technologies, LLC (US), SOFTAL Corona & Plasma GmbH (Germany), Coating Plasma Innovation (France), Ferrarini & Benelli (Italy), Neoplas GmbH (Germany), Terraplasma GmbH (Germany), Molecular Plasma Group SA (Germany), and CINOGY Technologies GmbH (Germany).
Research Coverage
This report studies the cold plasma market by industry, application, regime, and region. The report also examines factors such as drivers, restraints, opportunities, and challenges affecting market growth and provides details on the competitive landscape among market leaders. Furthermore, the report analyzes micromarkets by their individual growth trends and forecasts revenue for market segments across five major regions (and the countries within these regions).
Reasons to Buy the Report
The report will enable established firms, as well as entrants/smaller firms, to gauge the pulse of the market, which, in turn, will help them garner a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.
This report provides insights on the following pointers:
Analysis of key drivers (increased benefits and wider application, rising use in wound healing, growing applications in cancer and infectious disease, technological advancements, and rising demand for non-thermal sterilization and surface treatment), restraints (high capital investments and limited plasma penetration and non-uniform treatment), opportunities (sustainable and chemical-reduced processing and emerging countries offering opportunities), and challenges (limited commercialization and awareness and management of reactive species and process conditions)
Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global cold plasma market.
Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global cold plasma market
Market Development: Comprehensive information on the lucrative emerging markets by industry, application, and regime.
Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global cold plasma market.
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global cold plasma market.
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.3 STUDY SCOPE 29
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION 29
1.3.2 INCLUSIONS & EXCLUSIONS 30
1.3.3 YEARS CONSIDERED 31
1.3.4 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 32
2 EXECUTIVE SUMMARY 33
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 33
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 34
2.3 DISRUPTIVE TRENDS IN COLD PLASMA MARKET 36
2.4 HIGH-GROWTH SEGMENTS 37
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 COLD PLASMA MARKET OVERVIEW 39
3.2 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY AND END USER 40
3.3 GEOGRAPHIC SNAPSHOT OF COLD PLASMA MARKET 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 42
4.2 MARKET DYNAMICS 42
4.2.1 DRIVERS 43
4.2.1.1 Growing preference for low-temperature and chemical-reduced processing to drive cold plasma adoption 43
4.2.1.2 Rising use of cold plasma in wound healing 43
4.2.1.3 Emerging applications in oncology and infectious diseases 44
4.2.1.4 Technological advancements and product innovation 45
4.2.1.5 Rising demand for non-thermal sterilization and surface treatment for medical devices 46
4.2.2 RESTRAINTS 46
4.2.2.1 High initial investments 46
4.2.2.2 Limited plasma penetration and non-uniform treatment 47
4.2.3 OPPORTUNITIES 47
4.2.3.1 Growing focus on sustainable and chemical-reduced processing 47
4.2.3.2 Favorable prospects in emerging economies 48
4.2.4 CHALLENGES 49
4.2.4.1 Limited commercialization and awareness 49
4.2.4.2 Management of reactive species and process conditions during cold plasma operations 49
4.3 UNMET NEEDS AND WHITE SPACES 50
4.3.1 UNMET NEEDS IN COLD PLASMA MARKET 50
4.3.2 WHITE SPACE OPPORTUNITIES 51
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 52
4.4.1 INTERCONNECTED MARKETS 52
4.4.2 CROSS-SECTOR OPPORTUNITIES 52
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 53
5 INDUSTRY TRENDS 54
5.1 PORTER’S FIVE FORCES ANALYSIS 54
5.1.1 THREAT OF NEW ENTRANTS 55
5.1.2 THREAT OF SUBSTITUTES 56
5.1.3 BARGAINING POWER OF BUYERS 56
5.1.4 BARGAINING POWER OF SUPPLIERS 56
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 56
5.2 MACROECONOMIC OUTLOOK 56
5.2.1 INTRODUCTION 56
5.2.2 GDP TRENDS & FORECAST 57
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRIES 58
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 59
5.3 SUPPLY CHAIN ANALYSIS 59
5.4 VALUE CHAIN ANALYSIS 61
5.5 ECOSYSTEM ANALYSIS 63
5.6 PRICING ANALYSIS 65
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2023–2025) 65
5.6.2 AVERAGE SELLING PRICE TREND, BY REGIME (2023–2025) 66
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025) 66
5.7 TRADE ANALYSIS 68
5.7.1 IMPORT SCENARIO (HS CODE 901890) 68
5.7.2 EXPORT SCENARIO (HS CODE 901890) 69
5.8 KEY CONFERENCES & EVENTS, 2026–2027 69
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 70
5.10 INVESTMENT & FUNDING SCENARIO 72
5.11 CASE STUDY ANALYSIS 73
5.11.1 CASE STUDY 1: COLD ATMOSPHERIC ARGON PLASMA FOR
CHRONIC WOUND TREATMENT 73
5.11.2 CASE STUDY 2: PLASMA SURFACE ACTIVATION OF PEEK
FOR MEDICAL DEVICES 74
5.11.3 CASE STUDY 3: PLASMA ACTIVATION FOR HIGH-QUALITY PAD PRINTING 74
5.12 IMPACT OF 2025 US TARIFFS—COLD PLASMA MARKET 75
5.12.1 INTRODUCTION 75
5.12.2 KEY TARIFF RATES 75
5.12.3 PRICE IMPACT ANALYSIS 76
5.12.4 IMPACT ON COUNTRIES/REGIONS 76
5.12.4.1 Canada 76
5.12.4.2 Asia Pacific 77
5.12.4.3 Europe 77
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 78
6.1 KEY EMERGING TECHNOLOGIES 78
6.1.1 DIELECTRIC BARRIER DISCHARGE (DBD) 78
6.1.2 ATMOSPHERIC PRESSURE PLASMA JET (APPJ) 78
6.1.3 PLASMA-ACTIVATED WATER/LIQUID (PAW/PAL) 79
6.2 COMPLEMENTARY TECHNOLOGIES 79
6.2.1 ULTRAVIOLET LIGHT 79
6.2.2 HYDROGEN PEROXIDE-BASED STERILIZATION 80
6.2.3 LASER TECHNOLOGY 80
6.3 ADJACENT TECHNOLOGIES 81
6.3.1 NANOTECHNOLOGY AND ANTIMICROBIAL COATINGS 81
6.3.2 ADVANCED SURFACE TREATMENT TECHNOLOGIES 82
6.4 TECHNOLOGY/PRODUCT ROADMAP 82
6.4.1 NEAR-TERM (2025–2027) INCLUDES ALL INDUSTRIES 82
6.4.2 MID-TERM (2028–2030) 83
6.4.3 LONG-TERM (2030+) 85
6.5 PATENT ANALYSIS 86
6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS 87
6.6 FUTURE APPLICATIONS 89
6.6.1 PLASMA-ASSISTED PHARMACEUTICAL AND DRUG DELIVERY APPLICATIONS 90
6.6.2 ADVANCED AGRICULTURAL AND PLANT-PRODUCTION APPLICATIONS 90
6.6.3 FOOD WASTE VALORIZATION AND VALUE-ADDED FOOD PROCESSING 90
6.6.4 ADVANCED CONTAMINANT REMEDIATION IN WATER AND WASTEWATER 91
6.6.5 PLASMA-FUNCTIONALIZED BIOMATERIALS AND ADVANCED
THERAPEUTIC MATERIALS 91
6.7 IMPACT OF AI/GENERATIVE AI ON COLD PLASMA MARKET 91
6.7.1 TOP USE CASES AND MARKET POTENTIAL 92
6.7.2 BEST PRACTICES 93
6.7.3 CASE STUDIES OF AI IMPLEMENTATION 93
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT
ON MARKET PLAYERS 94
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN COLD PLASMA MARKET 94
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 96
7.1 REGIONAL REGULATIONS & COMPLIANCE 96
7.1.1 NORTH AMERICA 96
7.1.2 EUROPE 96
7.1.3 ASIA PACIFIC 97
7.1.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
7.1.5 INDUSTRY STANDARDS 102
7.1.5.1 Medical Electrical Equipment Safety Standard – IEC 60601-1 102
7.1.5.2 Non-thermal Plasma Wound-treatment Equipment Standard –
IEC 60601-2-91:2026 102
7.1.5.3 Quality Management System Standard For Medical Devices–
ISO 13485:2016 102
7.1.5.4 Cold Atmospheric Pressure Plasma Characterization Specification – DIN SPEC 91315:2025-07 102
7.1.5.5 Environmental Management System Standard – ISO 14001:2026 102
7.1.5.6 Quality Management System Standard – ISO 9001:2015 103
7.2 SUSTAINABILITY INITIATIVES 103
7.2.1 SUSTAINABLE SURFACE TREATMENT THROUGH ATMOSPHERIC
PLASMA – PLASMATREAT GMBH 103
7.2.2 REDUCING VOLATILE ORGANIC COMPOUND (VOCS) AND CHEMICAL USE THROUGH ATMOSPHERIC PLASMA – MYCRONIC 103
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 103
7.3.1 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 104
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 106
8.1 DECISION-MAKING PROCESS 106
8.1.1 DECISION-MAKING PROCESS 106
8.2 KEY STAKEHOLDERS & BUYING CRITERIA 109
8.2.1 BUYING CRITERIA 110
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 112
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 113
8.5 MARKET PROFITABILITY 114
9 COLD PLASMA MARKET, BY INDUSTRY 117
9.1 INTRODUCTION 118
9.2 POLYMER & PLASTIC INDUSTRY 119
9.2.1 GROWING ADOPTION OF ECO-FRIENDLY SURFACE
MODIFICATION TECHNOLOGIES 119
9.3 TEXTILE INDUSTRY 121
9.3.1 COLD PLASMA TECHNOLOGY OFFERS COST-SAVING AND ECO-FRIENDLY OPTIONS FOR TEXTILE PROCESSING 121
9.4 ELECTRONICS & SEMICONDUCTOR INDUSTRY 123
9.4.1 GROWING SEMICONDUCTOR INDUSTRY DEMANDS SUPPORT ADOPTION OF ADVANCED PLASMA PROCESSING TECHNOLOGIES 123
9.5 FOOD & AGRICULTURE INDUSTRY 125
9.5.1 GROWING ADOPTION OF NON-THERMAL TECHNOLOGIES FOR FOOD PROCESSING AND AGRICULTURAL APPLICATIONS 125
9.6 MEDICAL INDUSTRY 127
9.6.1 GROWING CLINICAL ADOPTION OF COLD PLASMA FOR WOUND HEALING AND ANTIMICROBIAL APPLICATIONS 127
9.7 COSMETICS INDUSTRY 129
9.7.1 EXPANDING APPLICATION OF COLD PLASMA IN DERMATOLOGICAL AND AESTHETIC TREATMENTS 129
9.8 PHARMACEUTICAL INDUSTRY 131
9.8.1 EXPANDING APPLICATION OF COLD PLASMA IN PHARMACEUTICAL STERILIZATION AND DRUG DELIVERY 131
9.9 OTHER INDUSTRIES 133
10 COLD PLASMA MARKET, BY APPLICATION 135
10.1 INTRODUCTION 136
10.2 SURFACE TREATMENT & ACTIVATION 137
10.2.1 INCREASING DEMAND FOR IMPROVED SURFACE ADHESION AND ACTIVATION IN POLYMER PROCESSING 137
10.3 COATING & THIN-FILM DEPOSITION 139
10.3.1 INCREASING APPLICATION OF COLD PLASMA FOR FUNCTIONAL
AND PROTECTIVE SURFACE COATINGS 139
10.4 PRINTING 140
10.4.1 BETTER DYE UPTAKE & PRINTING PERFORMANCE AND REDUCED RELIANCE ON WATER/CHEMICAL PRETREATMENT DRIVES ADOPTION 140
10.5 STERILIZATION & DECONTAMINATION 142
10.5.1 INCREASING APPLICATION OF COLD PLASMA FOR STERILIZATION & DECONTAMINATION DRIVES MARKET 142
10.6 WOUND HEALING 143
10.6.1 RISING PREVALENCE OF CHRONIC WOUNDS SUPPORTS USAGE OF COLD PLASMA IN WOUND MANAGEMENT 143
10.7 SURFACE ETCHING 145
10.7.1 INCREASING REQUIREMENT FOR HIGH-PRECISION PLASMA ETCHING IN SEMICONDUCTOR MANUFACTURING 145
10.8 SURGICAL APPLICATIONS 146
10.8.1 EXPANDING APPLICATIONS OF COLD PLASMA IN SURGICAL PROCEDURES AND CANCER TREATMENT 146
10.9 AESTHETIC SKIN PROCEDURES 148
10.9.1 INCREASING DEMAND FOR NON-SURGICAL AESTHETIC PROCEDURES SUPPORTS COLD PLASMA APPLICATIONS 148
10.10 OTHER APPLICATIONS 149
11 COLD PLASMA MARKET, BY REGIME 151
11.1 INTRODUCTION 152
11.2 ATMOSPHERIC COLD PLASMA 153
11.2.1 INCREASING ADOPTION OF ATMOSPHERIC COLD PLASMA FOR SCALABLE AND EFFICIENT SURFACE TREATMENT 153
11.3 LOW-PRESSURE COLD PLASMA 155
11.3.1 HIGH TREATMENT EFFECTIVENESS SUPPORTS APPLICATIONS DESPITE VACUUM-SYSTEM LIMITATIONS 155
12 COLD PLASMA MARKET, BY REGION 158
12.1 INTRODUCTION 159
12.2 NORTH AMERICA 159
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 160
12.2.2 US 163
12.2.2.1 Strong semiconductor investment, food-safety requirements, and medical applications support market growth 163
12.2.3 CANADA 166
12.2.3.1 Rising cancer cases & R&D to drive market growth in Canada 166
12.3 EUROPE 168
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 168
12.3.2 GERMANY 171
12.3.2.1 Strong industrial base and demand for sustainable processing technologies propel adoption 171
12.3.3 FRANCE 173
12.3.3.1 Strong electronics and semiconductor investments support cold plasma market growth 173
12.3.4 UK 175
12.3.4.1 Investments in semiconductor and agricultural technologies support cold plasma adoption 175
12.3.5 ITALY 177
12.3.5.1 Aging population and healthcare investment support cold plasma market growth 177
12.3.6 SPAIN 179
12.3.6.1 Growing healthcare needs and cancer burden support cold plasma applications in Spain 179
12.3.7 REST OF EUROPE 181
12.4 ASIA PACIFIC 183
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 183
12.4.2 CHINA 186
12.4.2.1 Strong textile, electronics, and food-processing industries support cold plasma adoption in China 186
12.4.3 JAPAN 189
12.4.3.1 Aging population, healthcare needs, and advanced manufacturing support cold plasma applications in Japan 189
12.4.4 INDIA 191
12.4.4.1 Growing R&D investment and textile exports support cold plasma adoption in India 191
12.4.5 AUSTRALIA 193
12.4.5.1 Growing healthcare needs and medical R&D support cold plasma adoption in Australia 193
12.4.6 SOUTH KOREA 195
12.4.6.1 Government support and advanced healthcare infrastructure support cold plasma adoption in South Korea 195
12.4.7 REST OF ASIA PACIFIC 197
12.5 LATIN AMERICA 199
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 199
12.5.2 BRAZIL 201
12.5.2.1 Growing R&D investment and healthcare innovation support cold plasma adoption in Brazil 201
12.5.3 MEXICO 203
12.5.3.1 Growing healthcare needs support cold plasma adoption in Mexico 203
12.5.4 REST OF LATIN AMERICA 205
12.6 MIDDLE EAST & AFRICA 207
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 207
12.6.2 GCC COUNTRIES 210
12.6.2.1 Kingdom of Saudi Arabia 212
12.6.2.1.1 Healthcare modernization and technology development drive cold plasma adoption in Saudi Arabia 212
12.6.2.2 UAE 214
12.6.2.2.1 Healthcare innovation and advanced technology development support cold plasma adoption in the UAE 214
12.6.2.3 Rest of GCC Countries 216
12.6.3 REST OF MIDDLE EAST & AFRICA 218
13 COMPETITIVE LANDSCAPE 220
13.1 INTRODUCTION 220
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026 220
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN COLD PLASMA MARKET 221
13.3 REVENUE ANALYSIS, 2023–2025 222
13.4 MARKET SHARE ANALYSIS, 2025 223
13.4.1 GLOBAL SHARE ANALYSIS FOR COLD PLASMA MARKET (2025) 223
13.4.2 US MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025) 225
13.4.3 EUROPE MARKET SHARE ANALYSIS FOR COLD PLASMA MARKET (2025) 226
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 228
13.5.1 STARS 228
13.5.2 EMERGING LEADERS 228
13.5.3 PERVASIVE PLAYERS 228
13.5.4 PARTICIPANTS 228
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 230
13.5.5.1 Company footprint 230
13.5.5.2 Region footprint 231
13.5.5.3 Industry footprint 232
13.5.5.4 Application footprint 233
13.5.5.5 Regime footprint 234
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 234
13.6.1 PROGRESSIVE COMPANIES 234
13.6.2 RESPONSIVE COMPANIES 234
13.6.3 DYNAMIC COMPANIES 235
13.6.4 STARTING BLOCKS 235
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 236
13.6.5.1 Detailed list of key startups/SMEs 236
13.6.5.2 Competitive benchmarking of key startups/SMEs 237
13.7 COMPANY VALUATION AND FINANCIAL METRICS 237
13.7.1 FINANCIAL METRICS 237
13.7.2 COMPANY VALUATION 238
13.8 BRAND/PRODUCT COMPARISON 239
13.9 COMPETITIVE SCENARIO 240
13.9.1 PRODUCT LAUNCHES & APPROVALS 240
13.9.2 DEALS 241
13.9.3 EXPANSIONS 242
13.9.4 OTHER DEVELOPMENTS 243
14 COMPANY PROFILES 244
14.1 KEY PLAYERS 244
14.1.1 NORDSON CORPORATION 244
14.1.1.1 Business overview 244
14.1.1.2 Products offered 245
14.1.1.3 Recent developments 247
14.1.1.3.1 Deals 247
14.1.1.3.2 Expansions 247
14.1.1.3.3 Other developments 248
14.1.1.4 MnM view 248
14.1.1.4.1 Right to win 248
14.1.1.4.2 Strategic choices 248
14.1.1.4.3 Weaknesses & competitive threats 249
14.1.2 ADTEC PLASMA TECHNOLOGY CO., LTD. 250
14.1.2.1 Business overview 250
14.1.2.2 Products offered 251
14.1.2.3 Recent developments 252
14.1.2.3.1 Product launches 252
14.1.2.3.2 Deals 252
14.1.2.3.3 Expansions 253
14.1.2.3.4 Other developments 253
14.1.2.4 MnM view 254
14.1.2.4.1 Right to win 254
14.1.2.4.2 Strategic choices 254
14.1.2.4.3 Weaknesses and competitive threats 254
14.1.3 JUDGES SCIENTIFIC PLC 255
14.1.3.1 Business overview 255
14.1.3.2 Products offered 256
14.1.3.3 Recent developments 257
14.1.3.3.1 Product launches & updates 257
14.1.3.3.2 Deals 258
14.1.3.4 MnM view 258
14.1.3.4.1 Right to win 258
14.1.3.4.2 Strategic choices 259
14.1.3.4.3 Weaknesses and competitive threats 259
14.1.4 PVA TEPLA AG 260
14.1.4.1 Business overview 260
14.1.4.2 Products offered 261
14.1.4.3 MnM view 262
14.1.4.3.1 Right to win 262
14.1.4.3.2 Strategic choices 262
14.1.4.3.3 Weaknesses and competitive threats 263
14.1.5 BODYCOTE 264
14.1.5.1 Business overview 264
14.1.5.2 Products offered 265
14.1.5.3 Recent developments 266
14.1.5.3.1 Other developments 266
14.1.5.4 MnM view 266
14.1.5.4.1 Right to win 266
14.1.5.4.2 Strategic choices 266
14.1.5.4.3 Weaknesses and competitive threats 266
14.1.6 APYX MEDICAL CORPORATION 267
14.1.6.1 Business overview 267
14.1.6.2 Products offered 268
14.1.6.3 Recent developments 269
14.1.6.3.1 Product launches & approvals 269
14.1.6.3.2 Other developments 270
14.1.7 VIROMED MEDICAL AG 271
14.1.7.1 Business overview 271
14.1.7.2 Products offered 272
14.1.7.3 Recent developments 272
14.1.7.3.1 Product approvals 272
14.1.7.3.2 Deals 273
14.1.7.3.3 Other developments 274
14.1.8 SAMCO INC. 275
14.1.8.1 Business overview 275
14.1.8.2 Products offered 276
14.1.8.3 Recent developments 277
14.1.8.3.1 Product launches 277
14.1.9 MYCRONIC 278
14.1.9.1 Business overview 278
14.1.9.2 Products offered 279
14.1.9.3 Recent developments 280
14.1.9.3.1 Deals 280
14.1.9.3.2 Other developments 281
14.1.10 PLASMATREAT GMBH 282
14.1.10.1 Business overview 282
14.1.10.2 Products offered 282
14.1.10.3 Recent developments 284
14.1.10.3.1 Product launches 284
14.1.10.3.2 Deals 285
14.1.10.3.3 Expansions 286
14.1.10.3.4 Other developments 286
14.1.11 P2I LTD 288
14.1.11.1 Business overview 288
14.1.11.2 Products offered 288
14.1.11.3 Recent developments 289
14.1.11.3.1 Deals 289
14.1.11.3.2 Other developments 289
14.1.12 ENERCON INDUSTRIES CORPORATION 290
14.1.12.1 Business overview 290
14.1.12.2 Products offered 290
14.1.12.3 Recent developments 291
14.1.12.3.1 Product launches 291
14.1.12.3.2 Expansions 291
14.1.13 TANTEC A/S 292
14.1.13.1 Business overview 292
14.1.13.2 Products offered 292
14.1.13.3 Recent developments 293
14.1.13.3.1 Product launches 293
14.1.13.3.2 Deals 293
14.1.14 ACXYS TECHNOLOGIES 294
14.1.14.1 Business overview 294
14.1.14.2 Products offered 294
14.1.14.3 Recent developments 295
14.1.14.3.1 Product launches 295
14.1.15 KEYLINK 296
14.1.15.1 Business overview 296
14.1.15.2 Products offered 296
14.1.15.3 Recent developments 297
14.1.15.3.1 Other developments 297
14.2 OTHER PLAYERS 299
14.2.1 DIENER ELECTRONIC GMBH & CO.KG 299
14.2.2 US MEDICAL INNOVATIONS 300
14.2.3 LEAFLIFE TECHNOLOGY 301
14.2.4 SOFTAL CORONA & PLASMA GMBH 301
14.2.5 FERRARINI & BENELLI SRL 302
14.2.6 NEOPLAS MED GMBH 303
14.2.7 TERRAPLASMA GMBH 304
14.2.8 MOLECULAR PLASMA GROUP 305
14.2.9 CINOGY TECHNOLOGIES GMBH 306
14.2.10 PLASMALEX 307
15 RESEARCH METHODOLOGY 308
15.1 RESEARCH DATA 308
15.1.1 SECONDARY DATA 309
15.1.1.1 Key data from secondary sources 310
15.1.2 PRIMARY DATA 311
15.1.2.1 Key data from primary sources 312
15.1.2.2 Key industry insights 313
15.1.2.3 Breakdown of primary interviews 313
15.1.2.4 Key industry insights 314
15.2 MARKET SIZE ESTIMATION 315
15.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 316
15.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 318
15.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS 319
15.2.4 TOP-DOWN APPROACH 319
15.2.5 BASE NUMBER CALCULATION 320
15.2.6 DEMAND-SIDE APPROACH 321
15.3 MARKET BREAKDOWN AND DATA TRIANGULATION 325
15.4 MARKET SHARE ASSESSMENT 326
15.5 RESEARCH ASSUMPTIONS 326
15.5.1 STUDY ASSUMPTIONS 326
15.5.2 GROWTH RATE ASSUMPTIONS 327
15.6 RISK ASSESSMENT 327
15.7 RESEARCH LIMITATIONS 327
16 APPENDIX 328
16.1 DISCUSSION GUIDE 328
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 332
16.3 CUSTOMIZATION OPTIONS 334
16.3.1 PRODUCT ANALYSIS 334
16.3.2 GEOGRAPHIC ANALYSIS 334
16.4 RELATED REPORTS 334
16.5 AUTHOR DETAILS 335
圖表清單 List of Tables & Figures
TABLE 1 COLD PLASMA MARKET: INCLUSIONS & EXCLUSIONS 30
TABLE 2 STANDARD CURRENCY CONVERSION RATES 31
TABLE 3 WHITE SPACE OPPORTUNITIES IN COLD PLASMA MARKET 51
TABLE 4 INTERCONNECTED MARKETS IN COLD PLASMA MARKET 52
TABLE 5 CROSS-SECTOR OPPORTUNITIES IN COLD PLASMA MARKET 52
TABLE 6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN COLD PLASMA MARKET 53
TABLE 7 COLD PLASMA MARKET: PORTER’S FIVE FORCES ANALYSIS 54
TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION) 57
TABLE 9 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS, BY KEY PLAYER, 2023–2025 (USD) 65
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY PLAYERS,
BY REGION (2023−2025) (USD) 67
TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2021–2025 (USD THOUSANDS) 68
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2021–2025 (USD THOUSANDS) 69
TABLE 13 COLD PLASMA MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027 69
TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES,2025 75
TABLE 15 COLD PLASMA MARKET: MAJOR PATENTS 88
TABLE 16 KEY COMPANIES IMPLEMENTING AI IN COLD PLASMA MARKET 92
TABLE 17 BEST PRACTICES IN COLD PLASMA MARKET 93
TABLE 18 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN
THE COLD PLASMA MARKET 93
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT
AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 99
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 100
TABLE 23 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY 110
TABLE 25 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY 112
TABLE 26 ADOPTION BARRIERS AND INTERNAL CHALLENGES IN THE COLD PLASMA MARKET 112
TABLE 27 UNMET NEEDS IN COLD PLASMA MARKET FROM VARIOUS END USERS 113
TABLE 28 COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 118
TABLE 29 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 30 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE POLYMER & PLASTIC INDUSTRY 120
TABLE 31 COLD PLASMA MARKET FOR THE POLYMER & PLASTIC INDUSTRY,
BY COUNTRY, 2024–2031 (USD MILLION) 120
TABLE 32 COMPARISON BETWEEN PLASMA TREATMENT AND TRADITIONAL TEXTILE PROCESSING 121
TABLE 33 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE TEXTILE INDUSTRY 121
TABLE 34 COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 35 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE ELECTRONICS & SEMICONDUCTOR INDUSTRY 123
TABLE 36 COLD PLASMA MARKET FOR ELECTRONICS & SEMICONDUCTOR INDUSTRY,
BY COUNTRY, 2024–2031 (USD MILLION) 124
TABLE 37 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE FOOD & AGRICULTURE INDUSTRY 125
TABLE 38 COLD PLASMA MARKET FOR THE FOOD & AGRICULTURE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 39 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR THE MEDICAL INDUSTRY 127
TABLE 40 COLD PLASMA MARKET FOR THE MEDICAL INDUSTRY, BY COUNTRY,
2024–2031 (USD MILLION) 128
TABLE 41 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR
THE COSMETICS INDUSTRY 129
TABLE 42 COLD PLASMA MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY,
2024–2031 (USD MILLION) 130
TABLE 43 KEY PLAYERS PROVIDING PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY 131
TABLE 44 COLD PLASMA MARKET FOR THE PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 132
TABLE 45 KEY PLAYERS PROVIDING COLD PLASMA PRODUCTS FOR OTHER INDUSTRIES 133
TABLE 46 COLD PLASMA MARKET FOR OTHER INDUSTRIES, BY COUNTRY,
2024–2031 (USD MILLION) 133
TABLE 47 COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 136
TABLE 48 COLD PLASMA MARKET FOR APPLICATION, BY COUNTRY,
2024–2031 (USD MILLION) 137
TABLE 49 COLD PLASMA MARKET FOR SURFACE TREATMENT & ACTIVATION, BY COUNTRY, 2024–2031 (USD MILLION) 138
TABLE 50 COLD PLASMA MARKET FOR COATING & THIN-FILM DEPOSITION,
BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 51 COLD PLASMA MARKET FOR PRINTING, BY COUNTRY, 2024–2031 (USD MILLION) 141
TABLE 52 COLD PLASMA MARKET FOR STERILIZATION & DECONTAMINATION,
BY COUNTRY, 2024–2031 (USD MILLION) 142
TABLE 53 COLD PLASMA MARKET FOR WOUND HEALING, BY COUNTRY,
2024–2031 (USD MILLION) 144
TABLE 54 COLD PLASMA MARKET FOR SURFACE ETCHING, BY COUNTRY,
2024–2031 (USD MILLION) 145
TABLE 55 COLD PLASMA MARKET FOR SURGICAL APPLICATIONS, BY COUNTRY,
2024–2031 (USD MILLION) 147
TABLE 56 COLD PLASMA MARKET FOR AESTHETIC SKIN PROCEDURES, BY COUNTRY,
2024–2031 (USD MILLION) 148
TABLE 57 COLD PLASMA MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2024–2031 (USD MILLION) 150
TABLE 58 COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 152
TABLE 59 COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 60 ATMOSPHERIC COLD PLASMA MARKET, BY REGION, BY VOLUME,
2024–2031 (MILLION UNITS) 154
TABLE 61 ATMOSPHERIC COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154
TABLE 62 LOW PRESSURE COLD PLASMA MARKET, BY REGION, BY VOLUME,
2024–2031 (MILLION UNITS) 156
TABLE 63 LOW-PRESSURE COLD PLASMA MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 156
TABLE 64 COLD PLASMA MARKET, BY REGION, 2024–2031 (USD MILLION) 159
TABLE 65 NORTH AMERICA: COLD PLASMA MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 161
TABLE 66 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 162
TABLE 67 NORTH AMERICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (MILLION UNITS) 162
TABLE 68 NORTH AMERICA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 162
TABLE 69 NORTH AMERICA: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 163
TABLE 70 US: MACROECONOMIC INDICATORS 164
TABLE 71 US: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 164
TABLE 72 US: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 165
TABLE 73 US: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165
TABLE 74 CANADA: MACROECONOMIC INDICATORS 166
TABLE 75 CANADA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 166
TABLE 76 CANADA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 167
TABLE 77 CANADA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 167
TABLE 78 EUROPE: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 169
TABLE 79 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 169
TABLE 80 EUROPE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 169
TABLE 81 EUROPE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 170
TABLE 82 EUROPE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 170
TABLE 83 GERMANY: MACROECONOMIC INDICATORS 171
TABLE 84 GERMANY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 172
TABLE 85 GERMANY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 172
TABLE 86 GERMANY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 173
TABLE 87 FRANCE: MACROECONOMIC INDICATORS 174
TABLE 88 FRANCE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 174
TABLE 89 FRANCE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 174
TABLE 90 FRANCE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175
TABLE 91 UK: MACROECONOMIC INDICATORS 176
TABLE 92 UK: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 176
TABLE 93 UK: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 176
TABLE 94 UK: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 177
TABLE 95 ITALY: MACROECONOMIC INDICATORS 178
TABLE 96 ITALY: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 178
TABLE 97 ITALY: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 178
TABLE 98 ITALY: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 179
TABLE 99 SPAIN: MACROECONOMIC INDICATORS 179
TABLE 100 SPAIN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 180
TABLE 101 SPAIN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 180
TABLE 102 SPAIN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 181
TABLE 103 REST OF EUROPE: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 181
TABLE 104 REST OF EUROPE: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 182
TABLE 105 REST OF EUROPE: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 182
TABLE 106 ASIA PACIFIC: COLD PLASMA MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 184
TABLE 107 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 185
TABLE 108 ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME, 2024–2031 (MILLION UNITS) 185
TABLE 109 ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 185
TABLE 110 ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 186
TABLE 111 CHINA: MACROECONOMIC INDICATORS 187
TABLE 112 CHINA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 187
TABLE 113 CHINA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 188
TABLE 114 CHINA: COLD PLASMA MARKET FOR THE TEXTILE INDUSTRY, BY APPLICATION, 2024–2031 (USD MILLION) 188
TABLE 115 JAPAN: MACROECONOMIC INDICATORS 189
TABLE 116 JAPAN: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 189
TABLE 117 JAPAN: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 190
TABLE 118 JAPAN: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190
TABLE 119 INDIA: MACROECONOMIC INDICATORS 191
TABLE 120 INDIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 191
TABLE 121 INDIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 192
TABLE 122 INDIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 192
TABLE 123 AUSTRALIA: MACROECONOMIC INDICATORS 193
TABLE 124 AUSTRALIA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 193
TABLE 125 AUSTRALIA: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 194
TABLE 126 AUSTRALIA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 194
TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS 195
TABLE 128 SOUTH KOREA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 195
TABLE 129 SOUTH KOREA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 196
TABLE 130 SOUTH KOREA: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 196
TABLE 131 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 197
TABLE 132 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 198
TABLE 133 REST OF ASIA PACIFIC: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 198
TABLE 134 LATIN AMERICA: COLD PLASMA MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 199
TABLE 135 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 200
TABLE 136 LATIN AMERICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (MILLION UNITS) 200
TABLE 137 LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 200
TABLE 138 LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 201
TABLE 139 BRAZIL: MACROECONOMIC INDICATORS 202
TABLE 140 BRAZIL: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 202
TABLE 141 BRAZIL: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 202
TABLE 142 BRAZIL: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 203
TABLE 143 MEXICO: MACROECONOMIC INDICATORS 203
TABLE 144 MEXICO: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 204
TABLE 145 MEXICO: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 204
TABLE 146 MEXICO: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 205
TABLE 147 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 206
TABLE 148 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 206
TABLE 149 REST OF LATIN AMERICA: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 207
TABLE 150 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGION,
2024–2031 (USD MILLION) 208
TABLE 151 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 208
TABLE 152 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (MILLION UNITS) 209
TABLE 153 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 209
TABLE 154 MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 210
TABLE 155 GCC COUNTRIES: COLD PLASMA MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 211
TABLE 156 GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 211
TABLE 157 GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 211
TABLE 158 GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 212
TABLE 159 KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS 212
TABLE 160 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 213
TABLE 161 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 213
TABLE 162 KINGDOM OF SAUDI ARABIA: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 214
TABLE 163 UAE: MACROECONOMIC INDICATORS 215
TABLE 164 UAE: COLD PLASMA MARKET, BY REGIME, 2024–2031 (USD MILLION) 215
TABLE 165 UAE: COLD PLASMA MARKET, BY INDUSTRY, 2024–2031 (USD MILLION) 215
TABLE 166 UAE: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 216
TABLE 167 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 216
TABLE 168 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 217
TABLE 169 REST OF GCC COUNTRIES: COLD PLASMA MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 217
TABLE 170 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY REGIME,
2024–2031 (USD MILLION) 218
TABLE 171 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY INDUSTRY,
2024–2031 (USD MILLION) 218
TABLE 172 REST OF MIDDLE EAST & AFRICA: COLD PLASMA MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219
TABLE 173 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS,
JANUARY 2023–JULY 2026 221
TABLE 174 COLD PLASMA MARKET: DEGREE OF COMPETITION 224
TABLE 175 US COLD PLASMA MARKET: DEGREE OF COMPETITION 226
TABLE 176 EUROPE COLD PLASMA MARKET: DEGREE OF COMPETITION 227
TABLE 177 COLD PLASMA MARKET: REGION FOOTPRINT 231
TABLE 178 COLD PLASMA MARKET: INDUSTRY FOOTPRINT 232
TABLE 179 COLD PLASMA MARKET: APPLICATION FOOTPRINT 233
TABLE 180 COLD PLASMA MARKET: REGIME FOOTPRINT 234
TABLE 181 COLD PLASMA MARKET: DETAILED LIST OF KEY STARTUPS/SMES 236
TABLE 182 COLD PLASMA MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUP/SME PLAYERS 237
TABLE 183 COLD PLASMA MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JULY 2026 240
TABLE 184 COLD PLASMA MARKET: DEALS, JANUARY 2023–JULY 2026 241
TABLE 185 COLD PLASMA MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 242
TABLE 186 COLD PLASMA MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 243
TABLE 187 NORDSON CORPORATION: COMPANY OVERVIEW 244
TABLE 188 NORDSON CORPORATION: PRODUCTS OFFERED 245
TABLE 189 NORDSON CORPORATION: DEALS, JANUARY 2023–JULY 2026 247
TABLE 190 NORDSON CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 247
TABLE 191 NORDSON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 248
TABLE 192 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 250
TABLE 193 ADTEC PLASMA TECHNOLOGY CO., LTD: PRODUCTS OFFERED 251
TABLE 194 ADTEC PLASMA TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES,
JANUARY 2023–JULY 2026 252
TABLE 195 ADTEC PLASMA TECHNOLOGY CO., LTD.: DEALS, JANUARY 2023–JULY 2026 252
TABLE 196 ADTEC PLASMA TECHNOLOGY CO., LTD.: EXPANSIONS, JANUARY 2023–JULY 2026 253
TABLE 197 ADTEC PLASMA TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS,
JANUARY 2023–JULY 2026 253
TABLE 198 JUDGES SCIENTIFIC PLC: COMPANY OVERVIEW 255
TABLE 199 JUDGES SCIENTIFIC PLC: PRODUCTS OFFERED 256
TABLE 200 JUDGES SCIENTIFIC PLC: PRODUCT LAUNCHES & UPDATES,
JANUARY 2023–JULY 2026 257
TABLE 201 JUDGES SCIENTIFIC PLC: DEALS, JANUARY 2023- JULY 2026 258
TABLE 202 PVA TEPLA AG: COMPANY OVERVIEW 260
TABLE 203 PVA TEPLA AG: PRODUCTS OFFERED 261
TABLE 204 BODYCOTE.: COMPANY OVERVIEW 264
TABLE 205 BODYCOTE: PRODUCTS OFFERED 265
TABLE 206 BODYCOTE: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 266
TABLE 207 APYX MEDICAL CORPORATION: COMPANY OVERVIEW 267
TABLE 208 APYX MEDICAL CORPORATION: PRODUCTS OFFERED 268
TABLE 209 APYX MEDICAL CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JULY 2026 269
TABLE 210 APYX MEDICAL CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2023–JULY 2026 270
TABLE 211 VIROMED MEDICAL AG: COMPANY OVERVIEW 271
TABLE 212 VIROMED MEDICAL AG: PRODUCTS OFFERED 272
TABLE 213 VIROMED MEDICAL AG: PRODUCT APPROVALS, JANUARY 2023–JULY 2026 272
TABLE 214 VIROMED MEDICAL AG: DEALS, JANUARY 2023- JULY 2026 273
TABLE 215 VIROMED MEDICAL AG: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 274
TABLE 216 SAMCO INC.: COMPANY OVERVIEW 275
TABLE 217 SAMCO INC.: PRODUCTS OFFERED 276
TABLE 218 SAMCO INC.: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 277
TABLE 219 MYCRONIC: COMPANY OVERVIEW 278
TABLE 220 MYCRONIC: PRODUCTS OFFERED 279
TABLE 221 MYCRONIC: DEALS, JANUARY 2023- JULY 2026 280
TABLE 222 MYCRONIC: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 281
TABLE 223 PLASMATREAT GMBH: COMPANY OVERVIEW 282
TABLE 224 PLASMATREAT GMBH: PRODUCTS OFFERED 282
TABLE 225 PLASMATREAT GMBH: PRODUCT LAUNCHES, JANUARY 2023–JULY 2026 284
TABLE 226 PLASMATREAT GMBH: DEALS, JANUARY 2023- JULY 2026 285
TABLE 227 PLASMATREAT GMBH: EXPANSIONS, JANUARY 2023–JULY 2026 286
TABLE 228 PLASMATREAT GMBH: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 286
TABLE 229 P2I LTD: COMPANY OVERVIEW 288
TABLE 230 P2I LTD: PRODUCTS OFFERED 288
TABLE 231 P2I LTD: DEALS, JANUARY 2023- JULY 2026 289
TABLE 232 P2I LTD: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 289
TABLE 233 ENERCON INDUSTRIES CORPORATION: COMPANY OVERVIEW 290
TABLE 234 ENERCON INDUSTRIES CORPORATION: PRODUCTS OFFERED 290
TABLE 235 ENERCON INDUSTRIES CORPORATION: PRODUCT LAUNCHES,
JANUARY 2023-JULY 2026 291
TABLE 236 ENERCON INDUSTRIES CORPORATION: EXPANSIONS, JANUARY 2023–JULY 2026 291
TABLE 237 TANTEC A/S: COMPANY OVERVIEW 292
TABLE 238 TANTEC A/S: PRODUCTS OFFERED 292
TABLE 239 TANTEC A/S: SERVICE LAUNCHES, JANUARY 2023- JULY 2026 293
TABLE 240 TANTEC A/S: DEALS, JANUARY 2023- JULY 2026 293
TABLE 241 ACXYS TECHNOLOGIES.: COMPANY OVERVIEW 294
TABLE 242 ACXYS TECHNOLOGIES: PRODUCTS OFFERED 294
TABLE 243 ACXYS TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2023- JULY 2026 295
TABLE 244 KEYLINK: COMPANY OVERVIEW 296
TABLE 245 KEYLINK: PRODUCTS OFFERED 296
TABLE 246 KEYLINK: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026 297
TABLE 247 STUDY ASSUMPTIONS 326
TABLE 248 COLD PLASMA MARKET: RISK ASSESSMENT ANALYSIS 327
FIGURE 1 MARKET SCENARIO 33
FIGURE 2 GLOBAL COLD PLASMA MARKET, 2024–2031 34
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS COLD PLASMA MARKET,
2024–2026 34
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF COLD PLASMA MARKET 36
FIGURE 5 HIGH-GROWTH SEGMENTS IN COLD PLASMA MARKET, 2026–2031 37
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN COLD PLASMA MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 38
FIGURE 7 INCREASING USE OF COLD PLASMA FOR STERILIZATION, SURFACE TREATMENT, AND DECONTAMINATION TO DRIVE MARKET GROWTH 39
FIGURE 8 POLYMER & PLASTICS INDUSTRY ACCOUNTED FOR LARGEST SHARE IN 2025 40
FIGURE 9 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 41
FIGURE 10 COLD PLASMA MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 42
FIGURE 11 COLD PLASMA MARKET: PORTER'S FIVE FORCES ANALYSIS 55
FIGURE 12 SUPPLY CHAIN ANALYSIS 61
FIGURE 13 COLD PLASMA PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 14 COLD PLASMA MARKET: ECOSYSTEM ANALYSIS 64
FIGURE 15 AVERAGE SELLING PRICE TREND OF COLD PLASMA PRODUCTS,
BY REGIME, 2023–2025 (USD) 66
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
IN COLD PLASMA MARKET 71
FIGURE 17 INVESTMENT & FUNDING SCENARIO (2023–2026) 73
FIGURE 18 COLD PLASMA MARKET: NUMBER OF GRANTED PATENT APPLICATIONS
(JANUARY 2016–JULY 2026) 86
FIGURE 19 TOP APPLICANT COUNTRIES/REGIONS FOR COLD PLASMA GENERATORS
(JANUARY 2016–JULY 2026) 88
FIGURE 20 KEY FEATURES OF AI/GENERATIVE AI IN COLD PLASMA MARKET 92
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY INDUSTRY 109
FIGURE 22 KEY BUYING CRITERIA FOR COLD PLASMA, BY INDUSTRY 111
FIGURE 23 NORTH AMERICA: COLD PLASMA MARKET SNAPSHOT (2025) 161
FIGURE 24 ASIA PACIFIC: COLD PLASMA MARKET SNAPSHOT (2025) 184
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN COLD PLASMA MARKET, 2023–2025 222
FIGURE 26 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 223
FIGURE 27 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 226
FIGURE 28 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 227
FIGURE 29 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 229
FIGURE 30 COLD PLASMA MARKET: COMPANY FOOTPRINT 230
FIGURE 31 COLD PLASMA MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 235
FIGURE 32 EV/EBITDA OF KEY VENDORS FOR COLD PLASMA MARKET 237
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS FOR COLD PLASMA MARKET 238
FIGURE 34 COLD PLASMA MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 239
FIGURE 35 NORDSON CORPORATION: COMPANY SNAPSHOT (2025) 245
FIGURE 36 ADTEC PLASMA TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2025) 251
FIGURE 37 JUDGES SCIENTIFIC PLC: COMPANY SNAPSHOT (2025) 256
FIGURE 38 PVA TEPLA AG: COMPANY SNAPSHOT (2025) 261
FIGURE 39 BODYCOTE: COMPANY SNAPSHOT (2025) 265
FIGURE 40 APYX MEDICAL CORPORATION: COMPANY SNAPSHOT (2025) 268
FIGURE 41 VIROMED MEDICAL AG: COMPANY SNAPSHOT (2025) 271
FIGURE 42 SAMCO INC.: COMPANY SNAPSHOT (2025) 276
FIGURE 43 MYCRONIC: COMPANY SNAPSHOT (2025) 279
FIGURE 44 COLD PLASMA MARKET: RESEARCH DESIGN 308
FIGURE 45 PRIMARY SOURCES 311
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 313
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 314
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS 314
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 316
FIGURE 50 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 317
FIGURE 51 REVENUE SHARE ANALYSIS ILLUSTRATION: NORDSON CORPORATION (2025) 318
FIGURE 52 BOTTOM-UP APPROACH 319
FIGURE 53 TOP-DOWN APPROACH 319
FIGURE 54 SUPPLY-SIDE ANALYSIS: COLD PLASMA MARKET (2025) 320
FIGURE 55 DEMAND-SIDE APPROACH 322
FIGURE 56 COLD PLASMA MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031) 323
FIGURE 57 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 324
FIGURE 58 MARKET DATA TRIANGULATION METHODOLOGY 325
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們